Company Filing History:
Years Active: 2012
Title: **Innovations of John Edward Mangette: Pioneering CCR10 Antagonists**
Introduction
John Edward Mangette, a notable inventor based in Clifton Park, NY, has made significant contributions to the field of pharmaceuticals. With one patent to his name, Mangette’s work primarily revolves around innovative compounds and their application in treating various diseases and disorders.
Latest Patents
Mangette's latest patent focuses on CCR10 antagonists, which are compounds represented by a specific formula. The invention comprises not only the compound itself but also methods of utilizing these compounds and the pharmaceutical compositions derived from them. These innovations show promise in addressing a variety of medical conditions by potentially enhancing treatment options for patients.
Career Highlights
As an inventor, Mangette has established a career that highlights his commitment to advancing therapeutic solutions. He is currently affiliated with Boehringer Ingelheim International GmbH, a renowned pharmaceutical company where he applies his expertise in drug development and innovation. His sole patent reflects not just his individual creativity, but also the rigorous research and development processes prevalent in the pharmaceutical industry.
Collaborations
In his role at Boehringer Ingelheim International GmbH, Mangette collaborates with esteemed colleagues such as Kaka Dey and Donghong Amy Gao. These partnerships are crucial in fostering an environment of innovation, allowing the team to leverage diverse expertise to enhance the development of new therapeutic compounds.
Conclusion
John Edward Mangette stands out as an influential inventor in the pharmaceutical sector, particularly for his work on CCR10 antagonists. His contributions, supported by collaborative efforts within Boehringer Ingelheim International GmbH, are paving the way for potential advancements in medical treatments, showcasing the importance of innovation in addressing healthcare challenges.